UnknownNot Applicable

Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren

United Kingdom26 participantsStarted 2021-01-22

Plain-language summary

This study assesses the content validity of the PGSQ for parents/carer of children with cerebral palsy and GORD, including features such as readability, face validity and acceptability for completion. This will be done via 6 interviews, with the PGSQ being altered as identified as required. Reliability (test-retest) of the adapted version of the PGSQ being assessed with a sample of 20 parents/carers.

Who can participate

Age range2 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parents or carers of children with cerebral palsy (GMFCS level III-V) with symptoms of GORD or on treatment for presumed GORD, aged between 2-16 years. Exclusion Criteria: * Children whose parent/carer are not able to support their participation in the study in the opinion of the investigator (e.g. language/communication issue, health, burden).

What they're measuring

Phase 1: Valid modified Paediatric Gastroesophageal Reflux Disease Symptom and Quality of Life Questionnaire (PGSQ)

Timeframe: 1 day

Trial details

NCT IDNCT04293107

SponsorPoole Hospital NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

Contact for this trial

Lee Tbaily

+44 (0)1202 442025 researchsponsorship@uhd.nhs.uk

View on ClinicalTrials.gov More Cerebral Palsy trials